JP2024546578A5 - - Google Patents

Info

Publication number
JP2024546578A5
JP2024546578A5 JP2024528581A JP2024528581A JP2024546578A5 JP 2024546578 A5 JP2024546578 A5 JP 2024546578A5 JP 2024528581 A JP2024528581 A JP 2024528581A JP 2024528581 A JP2024528581 A JP 2024528581A JP 2024546578 A5 JP2024546578 A5 JP 2024546578A5
Authority
JP
Japan
Prior art keywords
sequence
hsgsh
raav
mirna target
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024528581A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024546578A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/079701 external-priority patent/WO2023086928A2/en
Publication of JP2024546578A publication Critical patent/JP2024546578A/ja
Publication of JP2024546578A5 publication Critical patent/JP2024546578A5/ja
Pending legal-status Critical Current

Links

JP2024528581A 2021-11-12 2022-11-11 ムコ多糖症iiia型の治療のための遺伝子療法 Pending JP2024546578A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202163278775P 2021-11-12 2021-11-12
US63/278,775 2021-11-12
US202163288293P 2021-12-10 2021-12-10
US63/288,293 2021-12-10
PCT/US2022/079701 WO2023086928A2 (en) 2021-11-12 2022-11-11 Gene therapy for treatment of mucopolysaccharidosis iiia

Publications (2)

Publication Number Publication Date
JP2024546578A JP2024546578A (ja) 2024-12-26
JP2024546578A5 true JP2024546578A5 (cg-RX-API-DMAC7.html) 2025-11-18

Family

ID=86336670

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024528581A Pending JP2024546578A (ja) 2021-11-12 2022-11-11 ムコ多糖症iiia型の治療のための遺伝子療法

Country Status (10)

Country Link
US (1) US20250041445A1 (cg-RX-API-DMAC7.html)
EP (1) EP4430201A4 (cg-RX-API-DMAC7.html)
JP (1) JP2024546578A (cg-RX-API-DMAC7.html)
KR (1) KR20240133693A (cg-RX-API-DMAC7.html)
AU (1) AU2022388800A1 (cg-RX-API-DMAC7.html)
CA (1) CA3237987A1 (cg-RX-API-DMAC7.html)
CO (1) CO2024007283A2 (cg-RX-API-DMAC7.html)
IL (1) IL312676A (cg-RX-API-DMAC7.html)
MX (1) MX2024005735A (cg-RX-API-DMAC7.html)
WO (1) WO2023086928A2 (cg-RX-API-DMAC7.html)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2019013528A (es) * 2017-05-12 2020-07-14 The Children´S Hospital Of Philadelphia Variantes de sulfamidasa (sgsh) y vectores, composiciones, metodos y usos para tratar la mucopolisacaridosis tipo iiia (mps iiia).
US11555206B2 (en) * 2017-11-30 2023-01-17 The Trustees Of The University Of Pennsylvania Gene therapy for mucopolysaccharidosis IIIA
JP7577650B2 (ja) * 2018-10-10 2024-11-05 アミカス セラピューティックス インコーポレイテッド ジスルフィド結合により安定したポリペプチド組成物及びその使用方法
BR112021009913A2 (pt) * 2018-12-05 2021-08-17 Abeona Therapeutics, Inc. vetor viral adeno-associado recombinante para inserção gênica
MX2021007600A (es) * 2018-12-21 2021-08-11 Univ Pennsylvania Composiciones para la reduccion de la expresion transgenica especifica de drg.
US20220193261A1 (en) * 2019-04-30 2022-06-23 The Trustees Of The University Of Pennsylvania Compositions useful for treatment of pompe disease

Similar Documents

Publication Publication Date Title
JP2026027271A5 (cg-RX-API-DMAC7.html)
JP2022517174A5 (cg-RX-API-DMAC7.html)
JP2022530544A5 (cg-RX-API-DMAC7.html)
JP2022530633A5 (cg-RX-API-DMAC7.html)
JP2024009857A5 (cg-RX-API-DMAC7.html)
JP2020537544A5 (cg-RX-API-DMAC7.html)
JP2022530656A5 (cg-RX-API-DMAC7.html)
JP2023526310A5 (cg-RX-API-DMAC7.html)
JP2022531861A5 (cg-RX-API-DMAC7.html)
JP2022530095A5 (cg-RX-API-DMAC7.html)
CA3134485A1 (en) Compositions useful for treatment of pompe disease
JP2023524291A5 (cg-RX-API-DMAC7.html)
JP7702949B2 (ja) ヒトmecp2遺伝子を発現するように設計されたトランスジーンカセット
JP2022553406A5 (cg-RX-API-DMAC7.html)
WO2020142714A1 (en) Aav expression cassette and aav vectors comprising the same
JP2023545433A5 (cg-RX-API-DMAC7.html)
KR20250102136A (ko) 중추 신경계에서의 유전자 발현을 위한 핵산 조절 요소 및 사용 방법
JP2024542950A5 (cg-RX-API-DMAC7.html)
JP2024517104A5 (cg-RX-API-DMAC7.html)
CN120548368A (zh) 用于正确包装重复元件的腺相关病毒载体
TW202328446A (zh) 肌肉萎縮症之治療
JP2023509443A5 (cg-RX-API-DMAC7.html)
JP2025513066A5 (cg-RX-API-DMAC7.html)
JP2024543211A5 (cg-RX-API-DMAC7.html)
JP2023551254A5 (cg-RX-API-DMAC7.html)